ICO Badalona-Hospital Universitari Germans Trias I Pujol

Barcelona 08916

0 studies enrolling now · 4 studies all time

What they study most

Lymphoma, Non Hodgkin Lymphoma, Progressive Brain Metastasis, Solid Cancer, Unresectable or Metastatic Melanoma

Studies at this site

• A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Recruiting now
• An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma — Stopped early
• Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling
• Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas — Stopped early